Mintz has advised Synlogic Inc. Fenwick & West has advised Caldera Therapeutics. Cooley has advised the placement agents to Caldera Therapeutics. Synlogic, Inc. (OTC: SYBX) and...
Synlogic and Caldera Therapeutics Announce Merger and $278 Million Private Placement
Remix Therapeutics and Passage Bio Announce Merger and $100 Million Private Placement
Latham & Watkins LLP has advised Remix Therapeutics. Fenwick & West LLP has advised Passage Bio. Cooley LLP has advised Goldman Sachs & Co. LLC, Jefferies...
Rallybio to Acquire Avenzo Therapeutics and Complete $215 Million Private Placement
Cooley has advised Avenzo Therapeutics. Ropes & Gray has advised Rallybio Corporation. Mintz has advised the placement agents. Rallybio Corporation has entered into a definitive agreement...
Roche’s $1.5 Billion Acquisition of Poseida Therapeutics
Sidley Austin represented Roche in the transaction, and Cooley represented Poseida Therapeutics. Roche, one of the world’s largest biotechnology companies and the global leader in in-vitro...
Kura Oncology’s Collaboration with Kyowa Kirin
Wilson Sonsini Goodrich & Rosati and Cooley advised Kura Oncology. Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision...
BioAge Labs’ $238 Million Upsized Initial Public Offering
Fenwick & West represented BioAge Labs, Inc. in the offering, and Cooley represented the underwriters. BioAge Labs, Inc. (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic...
BiomX’s Merger with Adaptive Phage Therapeutics
Haynes and Boone is advising BiomX Inc. on the transaction, Cooley is advising Adaptive Phage Therapeutics and Wilmer Cutler Pickering Hale and Dorr is advising the...
AVROBIO’s Merger with Tectonic Therapeutic
Leerink Partners is serving as exclusive financial advisor to Tectonic and Cooley LLP is serving as legal counsel to Tectonic. Leerink Partners and TD Cowen are...
Neumora Therapeutics’ $250.1 Million Initial Public Offering
Latham & Watkins advised Neumora, and Cooley advised the underwriters. Neumora Therapeutics, Inc. announced the pricing of its initial public offering of 14,710,000 shares of its common...
Celadon Partners’ $38 Million Acquisition of Senti Bio’s Assets
Morrison Foerster advised Celadon Partners and GeneFab, while Cooley and Goodwin Procter advised Senti Biosciences. Senti Biosciences, Inc. (Nasdaq: SNTI) and Celadon Partners, LLC announced a transaction...
TransMedics Group’s Acquisition of Organ Support and Heart Preservation Transport System Assets from Bridge to Life
Ropes & Gray acted as legal advisor to TransMedics, and Cooley acted as legal advisor to Bridge to Life. TransMedics Group, Inc. (Nasdaq: TMDX) announced that is...
Turnstone Biologics Corp.’s $80 Million Initial Public Offering
Cooley represented Turnstone, and Latham & Watkins represented the underwriters in the IPO. Turnstone Biologics Corp. (Nasdaq: TSBX) announced the pricing of its upsized initial public...